Balance Sheet
Cash Flow Statement
AmortizationAmortizationAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in Working CapitalChange in Working CapitalDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Change in Intangibles (2020 - 2023)

Legend Biotech (LEGN) posted Change in Intangibles of -$96000.0 for Q3 2023, up 72.41% on a QoQ basis from -$348000.0 in Q2 2023, and down 110.51% year-over-year from $913000.0 in Q3 2022.

Legend Biotech (LEGN) has 4 years of Change in Intangibles data on file, last reported at -$96000.0 in Q3 2023.

  • In Q3 2023, Change in Intangibles fell 110.51% year-over-year to -$96000.0; the TTM figure through Sep 2024 stood at -$96000.0 (up 93.52% YoY), while the FY2022 annual figure was -$1.3 million, up 57.97% from the prior year.
  • Change in Intangibles climbed to -$96000.0 in Q3 2023, from -$348000.0 in the prior quarter.
  • Across five years, Change in Intangibles topped out at $913000.0 in Q3 2022 and bottomed at -$4.0 million in Q4 2020.
  • A 4-year average of -$987076.9 and a median of -$654000.0 in 2021 frame the typical range for Change in Intangibles.
  • Annual changes were most pronounced in 2021 — Change in Intangibles tumbled 528.33% — and 2022, when it soared 180.73%.
  • Year by year, Change in Intangibles stood at -$4.0 million in 2020, then increased by 20.4% to -$3.2 million in 2021, then surged by 57.97% to -$1.3 million in 2022, then soared by 92.88% to -$96000.0 in 2023.
  • The last three Change in Intangibles figures came in at -$96000.0 (Q3 2023), -$348000.0 (Q2 2023), and $310000.0 (Q1 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 68,980.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Revolution Medicines 32.39 Bn 32.39 Bn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2023 -96,000.00
Sep 30, 2023 -96,000.00
Jun 30, 2023 -348,000.00
Jun 30, 2023 -348,000.00
Mar 31, 2023 310,000.00
Mar 31, 2023 310,000.00
Dec 31, 2022 -1.35 Mn
Dec 31, 2022 -1.35 Mn
Sep 30, 2022 913,000.00
Sep 30, 2022 913,000.00
Jun 30, 2022 -881,000.00
Jun 30, 2022 -881,000.00
Mar 31, 2022 -411,000.00
Mar 31, 2022 -411,000.00
Dec 31, 2021 -3.21 Mn
Dec 31, 2021 -3.21 Mn
Sep 30, 2021 -1.13 Mn
Sep 30, 2021 -1.13 Mn
Jun 30, 2021 -654,000.00
Jun 30, 2021 -654,000.00
Mar 31, 2021 -1.77 Mn
Mar 31, 2021 -1.77 Mn
Dec 31, 2020 -4.03 Mn
Dec 31, 2020 -4.03 Mn
Sep 30, 2020 -180,000.00
Sep 30, 2020 -180,000.00